TMPRSS2 and prostate carcinoma: Also, a study conducted on 214 patients with prostate cancer demonstrated that the T allele of this variant, which is associated with the presence of Met amino acid, was associated with TMPRSS2-ERG fusion and, thus, might be important in prostate cancer pathogenesis [23].